118 related articles for article (PubMed ID: 15254420)
1. Comparison of genetic changes between interphase and metaphase nuclei in monitoring CML and APL treatment using DC-FISH technique.
Yakut T; Ali R; Egeli U; Ozkalemkas F; Ercan I; Ozçelik T; Ozkocaman V; Yigit B; Tunali A
Cancer Biol Ther; 2004 Sep; 3(9):858-63. PubMed ID: 15254420
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
3. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
[TBL] [Abstract][Full Text] [Related]
4. Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization.
Acar H; Stewart J; Connor MJ
Cancer Genet Cytogenet; 1997 Apr; 94(2):75-8. PubMed ID: 9109930
[TBL] [Abstract][Full Text] [Related]
5. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
6. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
Martinet D; Mühlematter D; Jotterand Bellomo M
Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
[TBL] [Abstract][Full Text] [Related]
7. Identification of variant translocations in chronic myeloid leukemia by fluorescence in situ hybridization.
Acar H; Stewart J; Boyd E; Connor MJ
Cancer Genet Cytogenet; 1997 Feb; 93(2):115-8. PubMed ID: 9078295
[TBL] [Abstract][Full Text] [Related]
8. [Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH].
Kim MK; Mun YC; Seong CM; Chung WS; Huh J
Korean J Lab Med; 2010 Dec; 30(6):711-7. PubMed ID: 21157160
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis.
Cuneo A; Bigoni R; Emmanuel B; Smit E; Rigolin GM; Roberti MG; Bardi A; Piva N; Scapoli G; Castoldi G; Van Den Berghe H; Hagemeijer A
Leukemia; 1998 Nov; 12(11):1718-23. PubMed ID: 9823946
[TBL] [Abstract][Full Text] [Related]
10. Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations.
Tanaka K; Arif M; Eguchi M; Kumaravel TS; Ueda R; Ohno R; Iwato K; Kyo T; Dohy H; Kamada N
Leukemia; 1997 Mar; 11(3):436-40. PubMed ID: 9067586
[TBL] [Abstract][Full Text] [Related]
11. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
Schoch C; Schnittger S; Bursch S; Gerstner D; Hochhaus A; Berger U; Hehlmann R; Hiddemann W; Haferlach T
Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
[TBL] [Abstract][Full Text] [Related]
12. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detection.
Garcia-Isidoro M; Tabernero MD; Garcia JL; Najera ML; Hernandez JM; Wiegant J; Raap A; San Miguel J; Orfao A
Hum Pathol; 1997 Feb; 28(2):154-9. PubMed ID: 9023395
[TBL] [Abstract][Full Text] [Related]
13. Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia.
Amiel A; Yarkoni S; Fejgin M; Gaber E; Nagler A; Manor Y; Lishner M
Cancer Genet Cytogenet; 1993 Jan; 65(1):32-4. PubMed ID: 8431913
[TBL] [Abstract][Full Text] [Related]
14. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
Mohr B; Bornhäuser M; Platzbecker U; Freiberg-Richter J; Naumann R; Prange-Krex G; Mohm J; Kroschinsky F; Ehninger G; Thiede C
Cancer Genet Cytogenet; 2001 Jun; 127(2):111-7. PubMed ID: 11425449
[TBL] [Abstract][Full Text] [Related]
15. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
Song YQ; Li W; Kong LH; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
Fugazza G; Miglino M; Bruzzone R; Quintino S; Gatti AM; Grasso R; Gobbi M; Frassoni F; Sessarego M
J Exp Clin Cancer Res; 2004 Jun; 23(2):295-9. PubMed ID: 15354415
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia.
Schad CR; Hanson CA; Paietta E; Casper J; Jalal SM; Dewald GW
Mayo Clin Proc; 1994 Nov; 69(11):1047-53. PubMed ID: 7967757
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
19. Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.
Nylund SJ; Ruutu T; Saarinen U; Larramendy ML; Knuutila S
Leukemia; 1994 Apr; 8(4):587-94. PubMed ID: 8152255
[TBL] [Abstract][Full Text] [Related]
20. FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib.
Reinhold U; Hennig E; Leiblein S; Niederwieser D; Deininger MW
Leukemia; 2003 Oct; 17(10):1925-9. PubMed ID: 14513039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
